USPTO 2015–2025 USPTO PatentsView US Corporation

Boston Scientific Scimed, Inc.

USPTO PatentsView assignee record — 3,361 granted patents across 128 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

3,361
Total patents granted
128
CPC technology areas
16.8
Avg claims per patent
+27%
5-year filing velocity

Portfolio overview

Boston Scientific Scimed, Inc. has been granted 3,361 US utility patents between 2015 and 2025, placing Boston Scientific Scimed, Inc. at rank #108 across all assignees tracked by PlainPatent. This portfolio spans 128 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Boston Scientific Scimed, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 70.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1,881 grants, compared with 1,480 in the 2015–2019 window — a +27% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Boston Scientific Scimed, Inc.'s 16.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Boston Scientific Scimed, Inc. against peers pursuing similar technology classes.

How does Boston compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Boston holds 3,361 patents — placing it at rank #108 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

200250300350400 20152016201720182019202020212022202320242025 313
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Boston Scientific Scimed, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 251 7.5%
2016 313 9.3%
2017 322 9.6%
2018 283 8.4%
2019 311 9.3%
2020 330 9.8%
2021 269 8.0%
2022 287 8.5%
2023 294 8.7%
2024 388 11.5%
2025 313 9.3%

Which technologies does Boston Scientific Scimed, Inc. patent most?

Top 15 of 128 technology areas

Patent Moat Analysis

Portfolio Volume Strong
Tech Breadth Diversified
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#108

Across all tracked assignees

Innovation Score

70.3 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Boston Scientific Scimed, Inc. hold?
Boston Scientific Scimed, Inc. holds 3,361 US granted patents filed between 2015 and 2025, spanning 128 technology areas.
What is Boston Scientific Scimed, Inc.'s Innovation Score?
Boston Scientific Scimed, Inc. has an Innovation Score of 70.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Boston Scientific Scimed, Inc. focus on?
Boston Scientific Scimed, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 2,362 patents. The company has filed patents in 128 CPC subclasses total.
Is Boston Scientific Scimed, Inc.'s patent filing rate increasing or decreasing?
Boston Scientific Scimed, Inc.'s recent filing velocity is +27% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Boston Scientific Scimed, Inc.'s patents?
Boston Scientific Scimed, Inc.'s patents average 16.8 claims each. This falls within the standard range, providing solid legal coverage.
How is the Boston Scientific Scimed, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope